Document is current
Any future updates will be listed below
-
Authors
Mima, Atsushi
Kimura, Azuma
Ito, Ryo
Hatano, Yu
Tsujimoto, Hiraku
Mae, Shin-Ichi
Yamane, Junko
Fujibuchi, Wataru
Uza, Norimitsu
Toyoda, Taro
Seno, Hiroshi
Osafune, Kenji
-
Funding
Funding for this research was provided by:
Rege Nephro Co., Ltd, Japan
Orizuru Therapeutics, Inc., Japan
Japan Agency for Medical Research and Development (JP23bm1123002)
Research Center Network for Realization of Regenerative Medicine
iPS Cell Research Fund, Japan
iPS Portal, Inc., Japan
- License Information
-
More Information
Article History
Received: 7 May 2024
Accepted: 30 January 2025
First Online: 7 February 2025
Declarations
:
: K.O. is a founder and member of the scientific advisory boards of iPS Portal, Inc., and a founder and chief scientific advisor of RegeNephro Co., Ltd. T.T. is a scientific adviser of Orizuru Therapeutics, Inc. A.K. and H.T. are an employee of RegeNephro Co., Ltd. There are no competing interests to declare by the other authors.
